Doctors undertake numerous tests to identify tumor presence and detect if it has spread. A number of tests are available to detect eye cancer. For the majority of tumors, a biopsy is the best method to identify any sort of malignancy. However, for eye melanoma a doctor may consider following factors when selecting a diagnostic test:

Age and health condition
Type of tumor suspected
Sternness of symptoms
Previous examination results
Besides physical examination, the following tests are used to identify eye tumor:

Eye examination: Most cases of melanoma are found during a routine physical examination by a doctor using a lighted device called an ophthalmoscope and a slit lamp (a microscope with a light attached to it).

Fluorescein Angiography: This process takes an image of the blood vessels in the eyeball. A glowing dye is injected into the patient’s arm. The dye moves all through the body and into the blood vessels in the back of the eye. The physician then takes numerous, immediate images of the eye. Fluorescein angiography may be used to exclude eye troubles other than tumor. Indocyanine green angiography is a parallel test that uses another dye, known as indocyanine green.

Fine needle biopsy: This process eliminates tumor cells from the eye with a pine needle. This permits a medical doctor to gaze at the cells under a microscope. Since doctors can properly identify more than 95% of intraocular melanoma exclusive of a biopsy, this process is not required for the majority of people.

Cytogenetics and gene expression profiling: Your doctor may advocate one of these tests to facilitate to collect more information about your prediction and healing options. Cytogenetics is done using a tissue sample detached during either a biopsy or a surgical procedure.

Tests for metastases and risk of metastases: A cancer that initiates in the eye can multiply through the blood to new parts of the body, usually the liver. The medical doctor may perceive if the cancer has spread to the liver by testing the levels of liver enzymes in the patient’s blood or through a computed tomography examination or an ultrasound of the liver.

Author's Bio: 

Powers Taylor LLP is a boutique litigation firm that represents people injured by unsafe drugs. The attorneys of Powers Taylor founded this firm to focus on client needs. We employ unique and creative litigation strategies to obtain decisive results for our clients.